Assessment of the Potential for Inducing Resistance in Multidrug Resistant Organisms From Exposure to Minocycline, Rifampin and Chlorhexidine Used to Treat Intravascular Devices.

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.00040-19

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Microbiology

Related search

New Drugs to Treat Multidrug-Resistant Tuberculosis: The Case for Bedaquiline

Therapeutics and Clinical Risk Management
2014English

Multidrug Resistance: In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer (Adv. Mater. 10/2018)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

Multidrug-Resistant Organisms on Patients’ Hands

JAMA Internal Medicine
Internal Medicine
2016English

Classification of Drugs to Treat Multidrug-Resistant Tuberculosis (MDR-TB): Evidence and Perspectives

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Linezolid Safety, Tolerability and Efficacy to Treat Multidrug- And Extensively Drug-Resistant Tuberculosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units

2017English

Can the Devices Used to Treat Obstructive Sleep Apnoea Syndrome Increase the Tendency to Gain Weight?

ENT Updates
2015English

A Case of Intravascular Lymphoma Complicated With Fournier's Syndrome Due to Multidrug-Resistant Pseudomonas Aeruginosa

Journal of clinical and experimental hematopathology : JCEH
Medicine
2011English

Healthcare Personnel Intestinal Colonization With Multidrug-Resistant Organisms

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy